肾移植前冠脉筛查中需血运重建的1类适应证患病率低
本研究通过系统综述与荟萃分析评估肾移植前冠脉筛查中检出美国心脏协会1类血运重建适应证(左主干狭窄>50%或射血分数<35%的多支病变)的频率。纳入44项研究,平均患病率为2%(范围0%-17%),近端前降支病变2%,左主干狭窄1%,多支病变10%,35%转诊有创冠脉造影。结论认为移植前筛查中1类适应证罕见。
要点
- 肾移植前冠脉筛查检出1类血运重建适应证的平均患病率仅2%。
- 多支冠脉病变患病率10%,近端前降支病变2%,左主干狭窄1%。
- 35%的患者被转诊进行有创冠脉造影,提示筛查后侵入性检查比例较高。
核心结论
- 肾移植前冠脉筛查中检出美国心脏协会1类血运重建适应证的情况罕见,平均患病率2%。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE和Embase 1998至2024年文献,纳入44项报告移植前筛查结果的研究。
主要发现
- 1类适应证平均患病率2%,异质性高,估计范围0%至17%。
- 近端前降支病变患病率2%,左主干狭窄1%,多支冠脉病变10%,35%转诊有创冠脉造影。
- 按性别、糖尿病或高血压患病率未见显著异质性。
关键数值与推荐
- 1类血运重建适应证定义为左主干狭窄>50%或射血分数<35%的多支病变。
- 主要终点为筛查中检出上述1类适应证的频率。
- 次要终点包括多支病变、近端前降支病变频率及有创冠脉造影人数。
临床怎么用
- 移植前常规冠脉筛查检出需血运重建的1类适应证概率低,临床决策需权衡筛查收益与侵入性检查风险。
局限性
- 研究间异质性高,1类适应证患病率估计范围宽(0%至17%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Coronary artery disease is a barrier to kidney transplantation. Many transplant programs mandate routine coronary artery disease screening. It remains unclear how many patients meet class 1 indication for revascularization. We conducted a meta-analysis to estimate the prevalence. Despite high frequency of screening, we found a relatively low prevalence of class 1 indication for coronary revascularization. BACKGROUND: Cardiovascular disease is the most common cause of morbidity and mortality in kidney transplant recipients. Screening for coronary disease is frequently required before kidney transplantation, but coronary intervention has not been shown to be beneficial except in complex coronary artery disease. The likelihood of finding significant coronary artery disease and the benefits of routine pretransplant screening are uncertain. METHODS: We performed a systematic review and meta-analysis. Medical Literature Analysis and Retrieval System Online and Excerpta Medica database were searched to identify manuscripts published between 1998 and 2024 reporting the results of pretransplant screening. The primary end points were the frequency of detecting significant coronary lesions for which there are American Heart Association class 1 indications for revascularization: ( 1 ) >50% left main stenosis or ( 2 ) multivessel disease with ejection fraction <35% during prekidney transplant screening. Secondary end points included frequency of detecting multivessel disease, proximal left anterior descending artery disease, and number of patients who underwent invasive coronary angiography. Meta-regression was used to explore outcome heterogeneity according to the presence of hypertension, diabetes, and age. RESULTS: We identified 1273 studies, out of which 44 met eligibility criteria. The mean prevalence of class 1 indications was 2%, although the heterogeneity was high with estimates ranging from 0% to 17%. Estimated prevalence of proximal left anterior descending disease was 2% and left main stenosis was 1%, whereas 10% of patients had multivessel coronary artery disease, and 35% were referred for invasive angiography. There was no evidence of significant heterogeneity according to sex of the population or prevalence of diabetes or hypertension. CONCLUSIONS: Identification of class 1 indications for revascularization during pretransplant coronary screening was rare. PODCAST: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/JASN/2026_01_08_ASN0000000890.mp3.
引用
- Israni A, Sandorffy BL, Liu CS, et al. Class 1 Indications for Coronary Revascularization Identified in Prekidney Transplant Screening. J Am Soc Nephrol. 2025. PMID: 41056088. doi:10.1681/ASN.0000000890
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。